Safety Alerts and Recalls
N-nitroso-varenicline may be associated with an increased cancer risk based on data from closely related nitrosamine compounds.
Safety Alerts and Recalls
To date, the Company has not received any reports of adverse events related to this recall.
Generics News
Par's generic version of Chantix is currently the only available one in the US.
News, Safety Alerts and Recalls
Long-term use of a product containing N-nitroso-varenicline may be associated with an increased cancer risk based on data from closely related nitrosamine compounds.
Safety Alerts and Recalls
The recalled lots of Chantix were distributed nationwide to wholesalers and distributors in the United States and Puerto Rico from May 2019 to September 2021.
CHEST 2021, News
Researchers evaluated the relationship between e-cigarettes and obstructive pulmonary diseases, taking into account age, gender, ethnicity, and body mass index.
Features
In this Q&A, Erica Johnson, MD, provides insight into the new oral antiviral medications that may soon be approved for the treatment of COVID-19.